Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 872 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Academic leaders respond to Medical Research Council call for urgent action on GP research workforce

UK academics call for urgent action to protect the academic GP workforce as government commits £29bn to shift NHS care from hospitals to community. New recommendations aim to safeguard world-leading primary care research.

How do vaccines reduce the risk of dementia?

A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in the following 18 months. The findings suggest a novel explanation for how vaccines produce this effect.

‘Single shot’ malaria vaccine delivery system could transform global immunisation

Oxford researchers have developed programmable microcapsules to deliver vaccines in stages, potentially eliminating the need for booster shots and increasing immunisation coverage in hard-to-reach communities.

Associate Professor reaches new heights with the Thames Valley Air Ambulance

David Metcalfe, Associate Professor of Emergency Medicine at Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), has begun a two-year secondment with Thames Valley Air Ambulance.

Alan Davidson Foundation renews funding for ground-breaking motor neuron disease research at Oxford

As part of its renewed commitment, the Alan Davidson Foundation will continue to fund a full-time project manager to facilitate the ongoing coordination and growth of the ACORN study. The foundation is also contributing to the cost of a research fellow to support the next phase of the project.

Oxford academics awarded European Research Council Advanced Grants for cutting-edge research

Seven researchers at the University of Oxford, including four from Medical Sciences, have been awarded Advanced Grants from the European Research Council, each worth up to €2.5 million over a period of five years.

Identification of a new metabolic axis underpinning cardiac dysfunction in diabetes

A new publication from Department of Physiology, Anatomy and Genetics identifies a new metabolic axis which explains why the diabetic heart becomes fatty.

Oxford’s OrganOx is shortlisted for the MacRobert Award 2025

The Royal Academy of Engineering has announced the finalists for the 2025 MacRobert Award, the longest running and most prestigious prize for UK engineering innovation.

Oxford neurosurgeon secures nearly £2 million for brain cancer trial

Associate Professor Puneet Plaha of the Nuffield Department of Surgical Sciences has been awarded a £1.98 million NIHR Health Technology Assessment (HTA) grant to lead a five-year clinical trial addressing one of the most critical questions in brain cancer care.

King's Birthday Honours 2025

Professor Andrew Carr has been recognised and celebrated in the 2025 King's Birthday Honours list.

Oxford researchers uncover a potential new therapeutic target for a hard-to-treat form of leukaemia

Researchers at the University of Oxford have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.

Oxford strengthens global mindfulness research with £1 million gift

The University of Oxford has announced a £1 million donation to advance the work of the Oxford Mindfulness Research Centre.

Intensive weight loss programme improves eating disorder symptoms in people with Type 2 Diabetes at risk of eating disorders, new study finds

New study finds intensive diet programmes safely improve eating disorder symptoms in people with type 2 diabetes. Research published in The Lancet Psychiatry challenges assumptions about weight loss interventions for vulnerable patients, potentially expanding treatment options.

New consortium to make UK a world leader in AI drug discovery

A new consortium, co-led by NDM researchers, has just been announced, aiming to make the UK a leader in artificial intelligence-driven drug discovery. The ‘OpenBind’ consortium will slash the cost of drug discovery and development by as much as £100 billion.

Early-career researcher wins £1.2 million Wellcome award

Mr Keaton Jones from the Nuffield Department of Surgical Sciences has secured a prestigious Wellcome Early-Career Award worth £1.2 million. His research will investigate the role of macrophages, a type of immune cell, and their metabolism in driving immunotherapy resistance in pancreatic cancer.

New research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia

Researchers at the University of Oxford have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.

Oxford vaccine against deadly Nipah virus granted European Medicines Agency PRIME designation

The University of Oxford’s vaccine to protect people from deadly Nipah virus has been granted support from the PRIority MEdicines (PRIME) scheme offered by Europe’s medicines regulator, the European Medicines Agency (EMA). It is the first UK academic institution to be awarded this designation.

Malaria vaccine wins Galien Foundation prize for Best Public Sector Innovation

The R21/Matrix-M malaria vaccine has received the Galien Foundation prize for Best Public Sector Innovation. Members of the Jenner Institute team, Prof Sir Adrian Hill, Mehreen Datoo and Lisa Stockdale were present during the Galien Foundation UK Forum & Awards Ceremony in London on 05 June 2025.

Study highlights effectiveness of neuromodulatory therapy on severe epileptic focal seizures

A long-term clinical study has confirmed the effectiveness of a neuromodulatory treatment for severe focal seizures in both children and adults with drug-resistant epilepsy (DRE) and demonstrated the therapy’s lasting impact.

New research identifies key driver of inflammation in spondyloarthritis

NDORMS researchers have identified a primary source of inflammatory IL-17 driving spondyloarthritis, paving the way for the development of targeted therapies to treat the condition.

Load More